Patients with pseudohypoparathyroidism type Ib (PHP-1b) develop resistance toward PTH, leading to hypocalcemia and hyperphosphatemia. PHP-1b is an imprinted human disorder associated with methylation changes at one or several differentially methylated regions at the GNAS locus. This complex locus gives rise to several different transcripts with different patterns of imprinted expression depending on promoter methylation. They can be either coding [G␣s, XL␣s, and neuroendocrine secretory protein-55 (NESP55)] or nontranslated (A/B and AS). The paternal AS transcript lies antisense to nesp55.
tory protein-55)] or nontranslated (A/B and AS) (1, 2) . AS (also known as nespas in mice) is transcribed in the antisense direction, in comparison with NESP (3, 4) . Their promoters and first exon are situated within differentially methylated regions (DMR) and their transcription is restricted to the nonmethylated parental allele (4 -7). The promoter regions for exons XL and AS as well as for A/B (exon 1A in mice) are methylated on the maternal allele and expression occurs only from the paternally inherited allele. Conversely, the exon coding for NESP55 shows methylation on the paternal allele and its transcript is derived from the maternally inherited allele.
In contrast, the promoter driving G␣s expression lacks differential methylation and the two alleles are supposed to be biallelically expressed in most tissues. However, in certain cells including the cells of renal proximal tubules, Gs␣ expression occurs only from the maternal allele and depends on the methylation status of the DMR for exon A/B that is situated immediately upstream. On the other hand, paternal expression of A/B had been predicted to suppress G␣s transcription (7) .
Patients affected by pseudohypoparathyroidism type Ib (PHP-1b) develop resistance to PTH leading to hypocalcemia and hyperphosphatemia, which can sometimes be associated with resistance to TSH (8) . PHP-1b is associated with loss of methylation (LoM) at the DMR comprising exon A/B. PHP-1b may follow an autosomal dominant (AD) pattern of inheritance (AD-PHP-1b) or appears to arise sporadically. AD-PHP-1b is caused by microdeletions on the maternal allele within the gene encoding syntaxin-16 (STX16) (9, 10) . Three other maternally inherited microdeletions involving NESP55 and AS (delNESP55/ASdel3-4) or AS (delAS3-4) have recently been identified (11, 12) . These deletions disrupt methylation of the three GNAS DMR (A/B, XL, and AS) when maternally inherited but also partially alter methylation of NESP55 and A/B DMR after paternal transmission.
In this paper, we have investigated a new AD-PHP-1b kindred and identified a novel deletion ablating NESP55. This deletion reveals a cis-acting element required for A/B imprinting with no impact on the imprinting of other DMR.
Materials and Methods

The kindred with AD-PHP-1b
Hypocalcemia associated with high PTH levels was found in patients presenting with history of seizure (patient 769) or experiencing tetanic spasms (patients 853 and 982). The pedigree and clinical and laboratory findings are depicted on Fig. 1, A and B .
Patient 982 presents with IV, V brachymetatarsia, and like his father, he is of small stature.
The three probands were cousins, indicating that the disease was inherited from their unaffected mothers (subjects 981 and 852).
DNA and RNA analysis
For additional details, see Supplemental Methods (published on The Endocrine Society's Journals Online web site at http://jcem.endojournals.org).
Leukocytes DNA were screened for GNAS mutations and STX16 deletion with procedures routinely used in the laboratory.
Dosage and differential methylation analyses were assessed by methylation-specific multiplex ligation-dependent probe amplification using the ME031-A1 kit (MRC-Holland, Amsterdam, The Netherlands) (13) . Quantification of the methylation was performed after bisulfite treatment and pyrosequencing.
Gene copy number was detected by array-comparative genomic hybridization (a-CGH) experiments (SurePrint HD Human CGH Microarray 4x44K; Agilent, Santa Clara, CA). 
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We studied 17 single-nucleotide polymorphism (SNP) markers, spanningtheclustertofindlossofheterozygosity,suggestingadeletion, and determined the deletion boundaries by genome walking.
To evaluate AS expression, total RNA isolated from the whole blood of patients 982 and 853 and their mothers (subjects 981 and 852) were subject to RT-PCR encompassing exons 4 -5.
Results
Methylation analysis of DNA from the three affected individuals revealed LoM at GNAS exon A/B according to the diagnosis of AD-PHP-1b ( Fig. 1C and Supplemental  Fig. 1A) without STX16 deletion. The methylation patterns at AS and XL DMR were normal.
The complete change of methylation of the NESP55 DMR with gain or loss of imprint in affected individuals and unaffected carriers, respectively, suggested either paternal uniparental isodisomy or a large deletion at this locus prompting us to test DNA using a-CGH.
A 20q13.32 deletion ablating NESP55 was revealed ( Fig. 2A) . Fine-mapping of the GNAS locus showed loss of heterozygosity at six SNP between exon 5 and exon 4 of AS in affected individuals and unaffected carriers (Supplemental Fig. 1B) . Genome walking using different sets of primer (Supplemental Fig. 2A ) allowed us to amplify genomic fragments on either side of the deleted region (Supplemental Fig. 2B ). Nucleotide sequence analysis of the PCR products revealed that the mutation deleted precisely 18,988 bp (nucleotides 57,397,711 to 57,416,700 according to hg19/GRCh37 assembly) combined with an insertion of A at the deleted site (Supplemental Fig. 2C ).
Because the deletion was located within AS intron 4, the AS transcript was analyzed with RT-PCR (Fig. 2B) . We observed a band corresponding to the predicted size (399 bp) of normal AS transcript in every subject. A double band of approximately 500 bp was seen in the individuals who are heterozygous for the deletion. One corresponds to a mutant AS sequence containing an additional sequence of 101 bp, that corresponds to nucleotides 57,416,722-57,416,700 and 57,397,711-57,397,632 located on intron 4, on either side of the deletion combined with the insertion of T (note that the sequence is antisense to the DNA sequence) (Fig. 2C) . The other band corresponds to a heteroduplex formed between the mutant and the wildtype (WT) transcripts. Finally, after sequencing, the PCR product of about 370 bp was found to be nonspecific.
Discussion
By using a-CGH combined with analysis of informative markers within the GNAS locus and PCR, we were able to identify a new deletion of 18,988 bp covering NESP55 in an AD-PHP1b family. This deletion respects the AS coding sequence and overlaps with the previously reported del-NESP55/delAS3-4 (11) and delAS3-4 (12) by only 342 bp ( Fig. 2A) . This is a CG-rich genomic sequence that fulfills the criteria of CpG islands and is methylated on the paternal allele (12) .
The methylation pattern within the cluster is different from the uniform loss of all maternal imprints caused by maternally inherited deletions delNESP55/ASdel3-4 and delAS3-4 (11, 12) or caused by patUPD20q (14 -16) . Common to all is an identical LoM at GNAS exon A/B DMR. The gain of methylation and the LoM in NESP55 DMR observed in the patients and the unaffected carrier, respectively, are directly linked to the deletion.
This deletion may disrupt a hitherto unrecognized cisacting element on the maternal allele that is required for establishing or maintaining maternal A/B methylation without affecting XL and AS DMR. Alternatively, it may reveal a function of either the maternally expressed NESP55 transcript or of AS noncoding macro-RNA (ncRNA).
In mice, targeted deletion of the nesp55 DMR (which also includes nespas2-4 in mice) on the maternal allele results in a LoM of the two downstream nespas/gnaxl and 1A DMR (17) . No effect on the imprinted DMR was observed after paternal transmission. These results recapitulate the epigenetic changes observed in patients with del nesp55/delAS3-4 (11) and delAS3-4 (12) but differ from those observed in the present study. These results therefore suggest that the methylation anomalies of AS/XL DMR may well be associated with the deletion of AS rather than that of NESP55.
The idea that transcription across DMR may in fact represent a crucial event in de novo methylation of DMR in female germ cells through interaction with the DNA methyltransferase and its cofactor is widely held to be true (18) . It is therefore possible that the absence of expression of NESP55 is the root cause of the observed abnormalities in methylation.
The role of nesp55 transcription was investigated in mice by designing a targeted allele to prematurely terminate transcription (Nesp trun ) (18) . All pups inheriting the Nesp trun allele maternally had a total lack of methylation of the 1A DMR. Once again, paternal transmission of Nesp trun had no effect. These results are thus not very different from those observed in the present study, suggesting that the NESP55 transcript has a role to play in the methylation of the A/B DMR.
There is also growing evidence for the importance of ncRNA in gene imprinting (19) ; AS is a paternally expressed ncRNA and runs antisense to NESP55 (3, 4) . In the two unaffected mothers, who had probably inherited the deletion on their paternal allele, AS is expressed in the form of two transcripts, one of which is a WT and the other mutated. It is probable that the WT allele corresponds to the normal splicing of the deleted paternal allele rather than the expression of the maternally inherited allele because there are no apparent methylation anomalies in the AS/XL DMR, although the possibility of subtle abnormalities that were not detected by the pyrosequencing technique used cannot be excluded. Similarly, in unaffected delAS3-4 carriers, only the paternal mutant AS transcript is expressed (12) . Because of the lack of informative SNP within the transcript, we were unable to draw a definitive conclusion. Conversely, when the deletion was situated on the maternal allele, we observed expression of the maternal mutant AS transcript and the expression of the paternal WT transcript, as found in delNESP55/ASdel3-4 and in delAS3-4 subjects (11, 12) . A cis-acting element that is removed by the deletion may lie within the NESP55 unit to silence AS. Alternatively, a transcript or transcription-mediated mechanisms could be envisaged whereby the expression of NESP55 mediates the silencing of AS. Conversely, evidence for nespas-mediated silencing of nesp has been provided in a knock-in mouse allele (nesp-T int2 ) (20) . Examined as a whole, these results suggest that there is reciprocal inhibition between the expression of NESP and AS. However, whether the LoM at A/B DMR is a consequence of loss of NESP expression or of the expression of AS remains to be determined.
